1Rosenberg SA,Power LB,Nooman KE,et al.Gene transfer into human immunotherapy of patient with advanced meranonia using tumor TIL modified by retroviral gene transduction[J].N Engl J Med,1990,328 (10):570.
2Maher J,Brentjens RJ,Gunset G,et al.Human T-lymphocyte cytotoxiclty and proliferation directed by a single chimeric TCRzeta/CD28 receptor[J].Nat Biotechnol,2002,20(1):70-75.
3Li,daqing,Ronson,Brian,et al.Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer[J].Cancer Rearch,2002,62(14):4023-4028.
4Ren H,Borlika T,Lundstrom K,et al.Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompatene Semliki forest virus vector carrying the human interleukin-12 gene-a phase Ⅰ / Ⅱ clinical protocol[J].J Neuroouool,2003,64(1-2):147-154.
5Morini M,Albini A,Lorusso G,et al.Prevertion of angiogenesis by naked DNA IL-12 gene transfer:angioprevertion by immunogene therapy[J].Gene Therapy,2004,11 (3):284-291.
6Sobol RE,Dinman JD,Icho T,et al.IL-2 gene therapy in a patient with glioblastoma[J].Gene Ther,1995,2(2):164.
7Croce M,Meazza R,Orego AM,et al,Sequential immunogene therspy with IL-12 and IL-15 engineened neuroblastma cells cures metastatic diease in syngereic mice[J].Clin-Cancer-Res,2005,11(2):735-742.
8Yamanaka R,Xanthopoulos KG,et al.Induction of antigen-specific Immune response against malignant brain tumor by intramuscular injection of sindbis DNA encoding gp100 and IL-18[J].DNA-Cell-Biol,2005,24(5):317-324.
9Schendel DJ,Fankenberger B,Jantzer P,et al.Expression of B7-1 (CD80) in a renal cell carcinoma line allows expansion of tumorassociated cytotoxic T lymphocytes in the presence of an alloresponse[J].Gene-Ther,2000,7(23):2007-2014.
10Takahashi T,Hirano N,Chibab S,et al.Immunogene therapy against mouse leukemia using B7 molecules[J].Cancer-Gene-Ther,2000,7 (1):144-150.
3[1]Van-Gool SW,Vandenberghe P,De-Boer M,et al.CD80,CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.Immunol Rev,1996,153:47-83.
4[2]Tatsumi T,Takahara T,Katayma K,et al.Expression of costimulatory molecules B7-1(CD80)and B7-2(86)on human hepatocellular carcinoma.Heptol,1997,25:1108-1114.
5[3]Sperling AI,Bluestone JA.The complexities of T-cell costimulation:CD28 and beyond.Immunol Rev,1996,153:155-183.
6[4]achmann MF,Mckall-Faienza K,Schmits R,et al.Distinct roles for LFA-1 and CD28 during activation of native cells:adhesion versus costimulation.Immunity,1997,7:549-557.
7[5]Viola A,Schroeder S,Sakakibara Y,et al.T-lymphocyte costimulation mediated by reorganization of membrane microdomains.Science,1999,283:680-682.
